ES2459492T3 - Vacunas de péptidos para cánceres de pulmón que expresan polipéptidos TTK, URLC10 o KOC1 - Google Patents

Vacunas de péptidos para cánceres de pulmón que expresan polipéptidos TTK, URLC10 o KOC1 Download PDF

Info

Publication number
ES2459492T3
ES2459492T3 ES10010438.9T ES10010438T ES2459492T3 ES 2459492 T3 ES2459492 T3 ES 2459492T3 ES 10010438 T ES10010438 T ES 10010438T ES 2459492 T3 ES2459492 T3 ES 2459492T3
Authority
ES
Spain
Prior art keywords
peptides
peptide
cells
hla
prt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES10010438.9T
Other languages
English (en)
Spanish (es)
Inventor
Takuya Tsunoda
Hideaki Tahara
Shuichi Nakatsuru
Yataro Daigo
Yusuke Nakamura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oncotherapy Science Inc
Original Assignee
Oncotherapy Science Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncotherapy Science Inc filed Critical Oncotherapy Science Inc
Application granted granted Critical
Publication of ES2459492T3 publication Critical patent/ES2459492T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • C12N9/1211—Thymidine kinase (2.7.1.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
ES10010438.9T 2005-02-25 2006-02-17 Vacunas de péptidos para cánceres de pulmón que expresan polipéptidos TTK, URLC10 o KOC1 Active ES2459492T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65685705P 2005-02-25 2005-02-25
US656857P 2005-02-25

Publications (1)

Publication Number Publication Date
ES2459492T3 true ES2459492T3 (es) 2014-05-09

Family

ID=36570330

Family Applications (3)

Application Number Title Priority Date Filing Date
ES10010438.9T Active ES2459492T3 (es) 2005-02-25 2006-02-17 Vacunas de péptidos para cánceres de pulmón que expresan polipéptidos TTK, URLC10 o KOC1
ES06714493T Active ES2364670T3 (es) 2005-02-25 2006-02-17 Vacunas de péptidos para cánceres de pulmón que expresan polipéptidos ttk.
ES10010439.7T Active ES2459466T3 (es) 2005-02-25 2006-02-17 Vacunas de péptidos para cánceres de pulmón que expresan polipéptidos TTK, URLC10 o KOC1

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES06714493T Active ES2364670T3 (es) 2005-02-25 2006-02-17 Vacunas de péptidos para cánceres de pulmón que expresan polipéptidos ttk.
ES10010439.7T Active ES2459466T3 (es) 2005-02-25 2006-02-17 Vacunas de péptidos para cánceres de pulmón que expresan polipéptidos TTK, URLC10 o KOC1

Country Status (9)

Country Link
US (2) US7847060B2 (enrdf_load_stackoverflow)
EP (3) EP2325306B1 (enrdf_load_stackoverflow)
JP (5) JP4461179B2 (enrdf_load_stackoverflow)
DE (1) DE602006021283D1 (enrdf_load_stackoverflow)
DK (2) DK2325306T3 (enrdf_load_stackoverflow)
ES (3) ES2459492T3 (enrdf_load_stackoverflow)
PL (2) PL2325305T3 (enrdf_load_stackoverflow)
PT (2) PT2325306E (enrdf_load_stackoverflow)
WO (1) WO2006090810A2 (enrdf_load_stackoverflow)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200413725A (en) * 2002-09-30 2004-08-01 Oncotherapy Science Inc Method for diagnosing non-small cell lung cancers
JP2010512730A (ja) * 2006-12-13 2010-04-30 オンコセラピー・サイエンス株式会社 肺癌の腫瘍マーカーおよび治療標的としてのｔｔｋ
TWI615403B (zh) * 2007-02-21 2018-02-21 腫瘤療法 科學股份有限公司 表現腫瘤相關抗原之癌症的胜肽疫苗
AU2012261725B2 (en) * 2007-02-21 2014-11-27 Oncotherapy Science, Inc. Peptide vaccines for cancers expressing tumor-associated antigens
JP2010535014A (ja) * 2007-07-30 2010-11-18 オンコセラピー・サイエンス株式会社 癌関連遺伝子ｌｙ６ｋ
UA100127C2 (ru) 2007-08-20 2012-11-26 Онкотерапи Саенс, Инк. Пептид cdh3 и лекарственное средство, содержащее его
TW201008574A (en) 2008-08-19 2010-03-01 Oncotherapy Science Inc INHBB epitope peptides and vaccines containing the same
TWI543767B (zh) * 2008-08-19 2016-08-01 腫瘤療法 科學股份有限公司 Ｈｉｇ２與ｕｒｌｃ１０抗原決定位胜肽以及含此胜肽之疫苗
BRPI0919766B1 (pt) 2008-10-22 2021-12-28 Oncotherapy Science, Inc. Oligopeptídeo, seu uso, agente farmacêutico ou composição para o tratamento e/ou profilaxia de câncer, e/ou prevenção de recorrência pósoperatória do mesmo, métodos in vitro para induzir uma célula apresentadora de antígeno e para induzir um ctl
TWI500932B (zh) 2008-12-05 2015-09-21 Oncotherapy Science Inc Ｗｄｒｐｕｈ抗原決定位胜肽以及含此胜肽之疫苗
CN104193816A (zh) 2008-12-24 2014-12-10 肿瘤疗法科学股份有限公司 C1orf59肽及包含它的疫苗
CA2753681A1 (en) * 2009-03-04 2010-09-10 Oncotherapy Science, Inc. Vangl1 peptides and vaccines including the same
TW201100090A (en) * 2009-04-01 2011-01-01 Oncotherapy Science Inc C6orf167 peptides and vaccines containing the same
TW201102081A (en) * 2009-05-11 2011-01-16 Oncotherapy Science Inc TTK peptides and vaccines including the same
ES2662325T3 (es) * 2009-09-03 2018-04-06 Toray Industries, Inc. Inductor de respuesta inmune
TW201124530A (en) * 2009-12-01 2011-07-16 Oncotherapy Science Inc IMP-3 oligopeptides and vaccines including the same
TW201200525A (en) * 2009-12-04 2012-01-01 Oncotherapy Science Inc MYBL2 peptides and vaccines containing the same
WO2012032763A1 (en) * 2010-09-07 2012-03-15 Oncotherapy Science, Inc. Vangl1 peptides and vaccines including the same
SG11201405578TA (en) * 2012-03-09 2014-11-27 Oncotherapy Science Inc Pharmaceutical composition containing peptide
JP6255594B2 (ja) * 2012-07-10 2018-01-10 オンコセラピー・サイエンス株式会社 Ｔｈ１細胞のＬＹ６Ｋエピトープペプチドおよびこれを含有するワクチン
TWI643867B (zh) * 2013-05-24 2018-12-11 日商腫瘤療法 科學股份有限公司 對於ｔｈ１細胞之ｉｍｐ－３抗原決定位胜肽及含此之疫苗
CN111925431B (zh) 2014-08-04 2025-04-15 肿瘤疗法科学股份有限公司 Koc1衍生的肽和包含它们的疫苗
US10576097B2 (en) * 2014-08-04 2020-03-03 Oncotherapy Science, Inc. URLC10-derived peptide and vaccine containing same
US20180200325A1 (en) * 2014-11-18 2018-07-19 Shionogi & Co., Ltd. Stabilized peptide composition
WO2021060343A1 (ja) * 2019-09-24 2021-04-01 オンコセラピー・サイエンス株式会社 Ｕｒｌｃ１０由来ペプチドまたはｄｅｐｄｃ１由来ペプチドを認識するヒトｔ細胞が発現するｔ細胞受容体

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4722848A (en) 1982-12-08 1988-02-02 Health Research, Incorporated Method for immunizing animals with synthetically modified vaccinia virus
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5679647A (en) 1993-08-26 1997-10-21 The Regents Of The University Of California Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides
US5804566A (en) 1993-08-26 1998-09-08 The Regents Of The University Of California Methods and devices for immunizing a host through administration of naked polynucleotides with encode allergenic peptides
US5739118A (en) 1994-04-01 1998-04-14 Apollon, Inc. Compositions and methods for delivery of genetic material
US5736524A (en) 1994-11-14 1998-04-07 Merck & Co.,. Inc. Polynucleotide tuberculosis vaccine
US5922687A (en) 1995-05-04 1999-07-13 Board Of Trustees Of The Leland Stanford Junior University Intracellular delivery of nucleic acids using pressure
WO1997005900A1 (en) 1995-08-03 1997-02-20 Rijksuniversiteit Te Leiden Cell derived antigen presenting vesicles
US5853719A (en) 1996-04-30 1998-12-29 Duke University Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA
JP2000516090A (ja) 1996-07-26 2000-12-05 スローン―ケッタリング インスティチュート フォー キャンサー リサーチ 遺伝子的免疫化のための方法と試薬
EP1007671B1 (de) 1997-04-07 2002-02-13 Roche Diagnostics GmbH Fanconi-gen ii
AU723543B2 (en) 1997-04-07 2000-08-31 Roche Diagnostics Gmbh Fanconi-gene II
FR2766205B1 (fr) 1997-07-16 2002-08-30 Inst Nat Sante Rech Med Nouveau procede de sensibilisation de cellules presentatrices d'antigene et nouveaux moyens pour la mise en oeuvre du procede
US6255055B1 (en) 1998-03-09 2001-07-03 Wisconsin Alumni Research Foundation c-myc coding region determinant-binding protein (CRD-BP) and its nucleic acid sequence
US20030236209A1 (en) * 1998-03-18 2003-12-25 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US20030045491A1 (en) * 2001-02-23 2003-03-06 Christoph Reinhard TTK in diagnosis and as a therapeutic target in cancer
WO2001072775A2 (en) 2000-03-29 2001-10-04 Diadexus, Inc. Polynucleotides and polypeptides as well as methods for diagnosing and treating lung cancer
EP1474528A4 (en) 2000-10-13 2006-06-14 Protein Design Labs Inc METHODS FOR DIAGNOSING PROSTATE CANCER, COMPOSITIONS AND METHODS FOR SCREENING PROSTATE CANCER MODULATORS
WO2002036142A2 (en) * 2000-11-03 2002-05-10 University Of Vermont And State Agricultural College Compositions for inhibiting grb7
JP4429604B2 (ja) 2001-02-21 2010-03-10 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド 診断におけるｔｔｋおよび癌における治療標的としてのｔｔｋ
JP2005527180A (ja) 2001-04-18 2005-09-15 プロテイン デザイン ラブス， インコーポレイテッド 肺がんの診断方法、肺がんの修飾因子の組成及びスクリーニングの方法
US7189507B2 (en) * 2001-06-18 2007-03-13 Pdl Biopharma, Inc. Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer
CA2460283A1 (en) 2001-10-31 2003-05-08 Pfizer Products Inc. Therapeutics and diagnostics for disorders of erythropoiesis
WO2003042661A2 (en) 2001-11-13 2003-05-22 Protein Design Labs, Inc. Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer
US20030232350A1 (en) * 2001-11-13 2003-12-18 Eos Biotechnology, Inc. Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer
JP2005525789A (ja) 2001-11-13 2005-09-02 プロテイン デザイン ラブス インコーポレイティド ガンの診断方法、ガンのモジュレータのスクリーニング組成物及び方法
US20070166704A1 (en) 2002-01-18 2007-07-19 Fei Huang Identification of polynucleotides and polypeptide for predicting activity of compounds that interact with protein tyrosine kinases and/or protein tyrosine kinase pathways
CN101613406A (zh) * 2002-06-06 2009-12-30 肿瘤疗法科学股份有限公司 与人结肠癌相关的基因和多肽
SI1548032T1 (sl) * 2002-09-12 2009-10-31 Oncotherapy Science Inc KDR peptidi in cepiva, ki obsegajo le-te
TW200413725A (en) 2002-09-30 2004-08-01 Oncotherapy Science Inc Method for diagnosing non-small cell lung cancers
US20060024692A1 (en) * 2002-09-30 2006-02-02 Oncotherapy Science, Inc. Method for diagnosing non-small cell lung cancers
CA2528094A1 (en) 2003-06-09 2005-01-13 Corixa Corporation Expression vectors for stimulating an immune response to cancer antigens
JP4721903B2 (ja) * 2004-01-29 2011-07-13 大日本住友製薬株式会社 新規腫瘍抗原蛋白質及びその利用
EP1584684A1 (en) 2004-02-20 2005-10-12 Samsung Electronics Co., Ltd. Breast cancer related protein, gene encoding the same, and method of diagnosing breast cancer using the protein and gene
US7700573B2 (en) 2004-03-23 2010-04-20 Oncotherapy Science, Inc. Method for diagnosing non-small lung cancer
CA2599875A1 (en) 2005-03-03 2006-09-08 Takeda Pharmaceutical Company Limited Preventive/therapeutic agent for cancer
JP2010512730A (ja) * 2006-12-13 2010-04-30 オンコセラピー・サイエンス株式会社 肺癌の腫瘍マーカーおよび治療標的としてのｔｔｋ
JP2010535014A (ja) * 2007-07-30 2010-11-18 オンコセラピー・サイエンス株式会社 癌関連遺伝子ｌｙ６ｋ
TW201008574A (en) * 2008-08-19 2010-03-01 Oncotherapy Science Inc INHBB epitope peptides and vaccines containing the same

Also Published As

Publication number Publication date
EP2325306B1 (en) 2014-02-12
DE602006021283D1 (de) 2011-05-26
JP2009173661A (ja) 2009-08-06
JP4493053B2 (ja) 2010-06-30
EP1853703A2 (en) 2007-11-14
DK2325306T3 (en) 2014-03-03
US7847060B2 (en) 2010-12-07
ES2364670T3 (es) 2011-09-12
WO2006090810A2 (en) 2006-08-31
US20110027302A1 (en) 2011-02-03
JP2009173662A (ja) 2009-08-06
PL2325305T3 (pl) 2014-07-31
US20090202576A1 (en) 2009-08-13
JP4461179B2 (ja) 2010-05-12
PT2325306E (pt) 2014-04-29
JP2009173660A (ja) 2009-08-06
HK1156076A1 (en) 2012-06-01
PL2325306T3 (pl) 2014-07-31
EP2325305B1 (en) 2014-02-12
JP4493054B2 (ja) 2010-06-30
EP1853703B1 (en) 2011-04-13
DK2325305T3 (en) 2014-03-03
HK1156077A1 (en) 2012-06-01
ES2459466T3 (es) 2014-05-09
PT2325305E (pt) 2014-04-29
JP2008530975A (ja) 2008-08-14
EP2325305A1 (en) 2011-05-25
EP2325306A1 (en) 2011-05-25
JP2010143924A (ja) 2010-07-01
WO2006090810A3 (en) 2007-03-29
US8614176B2 (en) 2013-12-24

Similar Documents

Publication Publication Date Title
ES2459492T3 (es) Vacunas de péptidos para cánceres de pulmón que expresan polipéptidos TTK, URLC10 o KOC1
EP2476697B1 (en) Peptide vaccines for cancers expressing MPHOSPH1 polypeptides
TWI615403B (zh) 表現腫瘤相關抗原之癌症的胜肽疫苗
HK1156076B (en) Peptide vaccines for lung cancers expressing ttk, urlc10 or koc1 polypeptides
HK1156077B (en) Peptide vaccines for lung cancers expressing ttk, urlc10 or koc1 polypeptides
HK1171024B (en) Peptide vaccines for cancers expressing mphosph1 polypeptides
HK1171026B (en) Peptide vaccines for cancers expressing depdc1 polypeptides
HK1171025B (en) Peptide vaccines for cancers expressing depdc1 polypeptides
HK1191030A (en) Peptide vaccines for cancers expressing mphosph1 or depdc1 polypeptides
HK1190419A (en) Peptide vaccines for cancers expressing mphosph1 or depdc1 polypeptides